Stenotrophomonas maltophilia as an Emerging Ubiquitous Pathogen: Looking Beyond Contemporary Antibiotic Therapy
Top Cited Papers
Open Access
- 30 November 2017
- journal article
- review article
- Published by Frontiers Media SA in Frontiers in Microbiology
- Vol. 8, 2276
- https://doi.org/10.3389/fmicb.2017.02276
Abstract
Stenotrophomonas maltophilia is a commensal and an emerging pathogen earlier noted in broad-spectrum life threatening infections among the vulnerable, but more recently as a pathogen in immunocompetent individuals. The bacteria are consistently being implicated in necrotizing otitis, cutaneous infections including soft tissue infection and keratitis, endocarditis, meningitis, acute respiratory tract infection (RTI), bacteraemia (with/without hematological malignancies), tropical pyomyositis, cystic fibrosis, septic arthritis, among others. S. maltophilia is also an environmental bacteria occurring in water, rhizospheres, as part of the animals' microflora, in foods, and several other microbiota. This review highlights clinical reports on S. maltophilia both as an opportunistic and as true pathogen. Also, biofilm formation as well as quorum sensing, extracellular enzymes, flagella, pili/fimbriae, small colony variant, other virulence or virulence-associated factors, the antibiotic resistance factors, and their implications are considered. Low outer membrane permeability, natural MDR efflux systems, and/or resistance genes, resistance mechanisms like the production of two inducible chromosomally encoded β-lactamases, and lack of carefully compiled patient history are factors that pose great challenges to the S. maltophilia control arsenals. The fluoroquinolone, some tetracycline derivatives and trimethoprim-sulphamethaxole (TMP-SMX) were reported as effective antibiotics with good therapeutic outcome. However, TMP-SMX resistance and allergies to sulfa together with high toxicity of fluoroquinolone are notable setbacks. S. maltophilia's production and sustenance of biofilm by quorum sensing enhance their virulence, resistance to antibiotics and gene transfer, making quorum quenching an imperative step in Stenotrophomonas control. Incorporating several other proven approaches like bioengineered bacteriophage therapy, Epigallocatechin-3-gallate (EGCG), essential oil, nanoemulsions, and use of cationic compounds are promising alternatives which can be incorporated in Stenotrophomonas control arsenal.Keywords
This publication has 147 references indexed in Scilit:
- Opportunistic pathogens enriched in showerhead biofilmsProceedings of the National Academy of Sciences of the United States of America, 2009
- Fluorescence Correlation Spectroscopy To Study Diffusion and Reaction of Bacteriophages inside BiofilmsApplied and Environmental Microbiology, 2008
- The mob responseEMBO Reports, 2008
- Induction of L1 and L2 β-Lactamases of Stenotrophomonas maltophiliaAntimicrobial Agents and Chemotherapy, 2008
- The biology and future prospects of antivirulence therapiesNature Reviews Microbiology, 2008
- Looking for Chinks in the Armor of Bacterial BiofilmsPLoS Biology, 2007
- A Cyclic AMP Receptor Protein-Regulated Cell-Cell Communication System Mediates Expression of a FecA Homologue in Stenotrophomonas maltophiliaApplied and Environmental Microbiology, 2007
- Diffusible Signal Factor-Dependent Cell-Cell Signaling and Virulence in the Nosocomial PathogenStenotrophomonas maltophiliaJournal of Bacteriology, 2007
- Characterization of Small-Colony-Variant Stenotrophomonas maltophilia Isolated from the Sputum Specimens of Five Patients with Cystic FibrosisJournal of Clinical Microbiology, 2007
- Differential Biofilm Formation and Motility Associated with Lipopolysaccharide/Exopolysaccharide-Coupled Biosynthetic Genes inStenotrophomonas maltophiliaJournal of Bacteriology, 2006